Tudor Investment Corp’s Evolus EOLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-31,562
Closed -$380K 3383
2025
Q1
$380K Buy
+31,562
New +$413K ﹤0.01% 2456
2023
Q4
Sell
-56,802
Closed -$519K 2493
2023
Q3
$519K Sell
56,802
-82,341
-59% -$738K 0.01% 1660
2023
Q2
$1.01M Buy
139,143
+33,853
+32% +$292K 0.01% 1310
2023
Q1
$891K Buy
105,290
+2,394
+2% +$21.6K 0.01% 1272
2022
Q4
$773K Buy
102,896
+20,902
+25% +$162K 0.02% 1292
2022
Q3
$660K Buy
81,994
+51,151
+166% +$542K 0.01% 1200
2022
Q2
$358K Buy
+30,843
New +$364K 0.01% 1457
2020
Q1
Sell
-34,797
Closed -$423K 1123
2019
Q4
$423K Buy
+34,797
New +$491K 0.02% 769

Other funds holding EOLS

Tudor Investment Corp's EOLS Position: Q2 2025 in Review

Tudor Investment Corp sold out of Evolus (EOLS) in Q2 2025, closing a stake of 31,562 shares — an estimated $380K sold.

Tudor Investment Corp first reported a position in EOLS in Q4 2019 and held it in 8 quarters. The position peaked at $1.01M in Q2 2023. 172 funds tracked by Wall St. Rank hold EOLS as of Q2 2025.

  • Tudor Investment Corp reported no remaining Evolus position as of Q2 2025 after selling out during the quarter.
  • Tudor Investment Corp sold 31,562 Evolus shares in Q2 2025, an estimated $380K.
  • Tudor Investment Corp first reported a position in Evolus in Q4 2019 and held it in 8 quarters.
  • Tudor Investment Corp's Evolus position peaked at $1.01M in Q2 2023.
  • 172 funds tracked by Wall St. Rank held Evolus as of Q2 2025.

Based on Tudor Investment Corp's 13F filing for Q2 2025, filed 14 Aug 2025.